F. Bonella (Düsseldorf, Germany), S. Harari (Milano (MI), Italy)
Genetic landscape of pulmonary langerhans cell histiocytosis
F. Jouenne (Paris, France), G. Lorillon (Paris, France), C. Laurent-Issartel (Paris, France), A. Sadoux (Paris, France), V. Meignin (Paris, France), C. Leschi (Paris, France), E. Bugnet (Paris, France), S. Mourah (Paris, France), A. Tazi (Paris, France)
|  |
Chemotherapy in patients with pulmonary Langerhans cell histiocytosis
E. Radzikowska (Warsaw, Poland), E. Wiatr (Warsaw, Poland), K. Blasnska-Przerwa (Warsaw, Poland), K. Roszkowski-Sliz (Warsaw, Poland)
|   |
Fatal cases of pulmonary alveolar proteinosis: a nationwide surveillance in Japan
Y. Inoue (Osaka, Japan), E. Yamaguchi (AIchi, Japan), Y. Setoguchi (Tokyo, Japan), T. Ichiwata (Tokyo, Japan), M. Ebina (Miyagi, Japan), K. Cho (Hokkando, Japan), R. Tazawa (Niigata, Japan), H. Ishii (Tokyo, Japan), T. Kasai (Osaka, Japan), M. Akira (Osaka, Japan), T. Arai (Osaka, Japan), K. Uchida (Tokyo, Japan), H. Kida (Osaka, Japan), K. Morimoto (Nagasaki, Japan), M. Kitaichi (Wakayama, Japan), C. Sugimoto (Osaka, Japan), K. Nakata (Niigata, Japan), K. Katayama (Osaka, Japan), N. Takeuchi (Osaka, Japan), A. Matsumuro (Osaka, Japan)
| |
Characterization of the gene network driving the whole lung lavage (WLL) outcome in Pulmonary Alveolar Proteinosis (PAP).
M. Zorzetto (Pavia, Italy), F. Bonella (Essen, Germany), F. Mariani (Pavia, Italy), E. Paracchini (Pavia, Italy), Z. Kadija (Pavia, Italy), M. Grassi (Pavia, Italy), F. Meloni (Pavia, Italy), I. Campo (Pavia, Italy)
| |
Vascular endothelial growth factors and matrix metalloproteinases serum levels for LAM diagnosis in patients with sporadic LAM and tuberous sclerosis
S. Terraneo (Milan, Italy), F. Di Marco (Milan, Italy), G. Imeri (Milan, Italy), L. Giuliani (Milan, Italy), S. Ancona (Milan, Italy), P. Cetrangolo (Milan, Italy), E. Grasso (Milan, Italy), S. Centanni (Milan, Italy), E. Lesma (Milan, Italy)
| |
A national registry for childhood interstitial and diffuse lung diseases in the United States.
L. Young (Nashville, United States of America), R. Nevel (Nashville, United States of America), A. Casey (Boston, United States of America), M. Fishman (Boston, United States of America), S. Welsh (Boston, United States of America), D. Liptzin (Aurora, United States of America), J. Hagood (La Jolla, United States of America), G. Kurland (Pittsburgh, United States of America), D. Craven (Cleveland, United States of America), E. Fiorino (New Hyde Park NY, United States of America), J. Taylor (Kansas City, United States of America), S. Goldfarb (Philadelphia, United States of America), C. Conrad (Palo Alto, United States of America), C. Kuo (Palo Alto, United States of America), G. Deutsch (Seattle, United States of America), A. De (Bronx, United States of America), M. Powers (Portland, United States of America), R. Deterding (Aurora, United States of America)
| |
Pulmonary interstitial Glycogenosis – a systematic analysis of new cases
E. Seidl (Munich, Germany), J. Carlens (Hannover, Germany), S. Reu (Munich, Germany), M. Wetzke (Hannover, Germany), J. Ley-Zaporozhan (Munich, Germany), F. Brasch (Munich, Germany), W. Wesselak (Munich, Germany), A. Schams (Munich, Germany), D. Rauch (Munich, Germany), L. Schuch (Munich, Germany), M. Kappler (Munich, Germany), P. Schelstraete (Munich, Belgium), M. Wolf (Hamburg, Germany), F. Stehling (Essen, Germany), E. Haarmann (Amsterdam, Netherlands), D. Borensztajn (Amsterdam, Netherlands), M. Van De Loo (Amsterdam, Netherlands), S. Rubak (Aarhus, Denmark), B. Hinrichs (Munich, Germany), N. Schwerk (Hannover, Germany), M. Griese (Munich, Germany)
| |